These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. Zeremski M, Petrovic LM, Talal AH. J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002 [Abstract] [Full Text] [Related]
3. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F. Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540 [Abstract] [Full Text] [Related]
4. Chemokines in liver inflammation and fibrosis. Wasmuth HE, Tacke F, Trautwein C. Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374 [Abstract] [Full Text] [Related]
5. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, Luedde T, Trautwein C, Tacke F. Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415 [Abstract] [Full Text] [Related]
6. Chemokines as immune mediators of liver diseases related to the metabolic syndrome. Berres ML, Nellen A, Wasmuth HE. Dig Dis; 2010 Nov; 28(1):192-6. PubMed ID: 20460910 [Abstract] [Full Text] [Related]
7. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. Viebahn CS, Benseler V, Holz LE, Elsegood CL, Vo M, Bertolino P, Ganss R, Yeoh GC. J Hepatol; 2010 Sep; 53(3):500-7. PubMed ID: 20561705 [Abstract] [Full Text] [Related]
8. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I, Putter H, van Berkel TJ, Nagelkerken L, Jukema JW, Biessen EA. Circulation; 2007 Oct 23; 116(17):1931-41. PubMed ID: 17909104 [Abstract] [Full Text] [Related]
9. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines]. Wasmuth HE, Weiskirchen R. Z Gastroenterol; 2010 Jan 23; 48(1):38-45. PubMed ID: 20072995 [Abstract] [Full Text] [Related]
10. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Pokkali S, Das SD. Hum Immunol; 2009 Feb 23; 70(2):110-5. PubMed ID: 19100801 [Abstract] [Full Text] [Related]
11. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Zimmermann HW, Tacke F. Inflamm Allergy Drug Targets; 2011 Dec 23; 10(6):509-36. PubMed ID: 22150762 [Abstract] [Full Text] [Related]